[go: up one dir, main page]

BR0212679A - Inibição de produção de exoproteìna usando composições aromáticas - Google Patents

Inibição de produção de exoproteìna usando composições aromáticas

Info

Publication number
BR0212679A
BR0212679A BR0212679-6A BR0212679A BR0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A
Authority
BR
Brazil
Prior art keywords
unsaturated aliphatic
aliphatic hydrocarbyl
hydrocarbyl moiety
saturated
aromatic
Prior art date
Application number
BR0212679-6A
Other languages
English (en)
Inventor
Rae Ellen Syverson
Richard A Proctor
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR0212679A publication Critical patent/BR0212679A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45Mixtures of two or more drugs, e.g. synergistic mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

"INIBIçãO DE PRODUçãO DE EXOPROTEìNA USANDO COMPOSIçõES AROMáTICAS". Artigos absorventes e não absorventes são mostrados. os artigos incluem uma quantidade efetiva de um composto inibidor aromático para inibir substancialmente a produção de exotoxinas por bactérias Gram-positivas. Os compostos inibidores aromáticos da presente invenção têm a fórmula geral (I), onde R^ 1^ é selecionado a partir do grupo que consiste em H, (a), OR^ 5^, -R^ 6^C(O)H, -R^ 6^OH, -R^ 6^COOH, -OR^ 6^OH, -OR^ 6^COOH, -C(O)NH~ 2~, fórmula (1) e NH~ 2~ e sais do mesmo; R^ 5^ é uma porção hidrocarbila alifática saturada ou insaturada monovalente; R^ 6^ é uma porção hidrocarbila alifática saturada ou insaturada divalente; R^ 7^ é uma porção hidrocarbila alifática saturada ou insaturada trivalente; R^ 8^ é uma porção hidrocarbila alifática saturada ou insaturada substituída ou não substituída monovalente, a qual pode ou não ser interrompida com heteroátomos; R^ 2^, R^ 3^ e R^ 4^ são independentemente selecionados a partir do grupo que consiste em H, OH, COOH, e -C (O) R^ 9^; R^ 9^ é hidrogênio ou uma porção hidrocarbila alifática saturada ou insaturada monovalente.
BR0212679-6A 2001-10-02 2002-09-09 Inibição de produção de exoproteìna usando composições aromáticas BR0212679A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
PCT/US2002/028756 WO2003030953A1 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Publications (1)

Publication Number Publication Date
BR0212679A true BR0212679A (pt) 2005-04-12

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212679-6A BR0212679A (pt) 2001-10-02 2002-09-09 Inibição de produção de exoproteìna usando composições aromáticas

Country Status (9)

Country Link
EP (1) EP1432459A1 (pt)
JP (1) JP2005523239A (pt)
KR (1) KR100918887B1 (pt)
AR (1) AR037505A1 (pt)
AU (1) AU2002336472B2 (pt)
BR (1) BR0212679A (pt)
CA (1) CA2461291A1 (pt)
MX (1) MXPA04002474A (pt)
WO (1) WO2003030953A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
DK3223764T3 (da) * 2014-11-27 2023-11-20 Univ Yeditepe Antimikrobielle og antivirale hygiejneprodukter
CA3039556C (en) * 2016-10-09 2021-06-15 Shenzhen Eulikan Biotechnology Co., Ltd. Use of 2-phenylethanol in combination with other antimicrobial agents for vagina

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (de) * 1994-04-05 1995-10-12 Beiersdorf Ag Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen
JPH07289575A (ja) * 1994-04-27 1995-11-07 Okamoto Ind Inc 香料添加コンドーム及びコンドームへの香料添加方法
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
JP4044959B2 (ja) * 1995-06-07 2008-02-06 キンバリー クラーク ワールドワイド インコーポレイテッド 吸収性物品中のエクソプロテインの阻害
JPH09108257A (ja) * 1995-10-23 1997-04-28 Shiyouichi Masugi 蓄光性クリーム及びラテックス製コンドーム
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
JP2001502302A (ja) * 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
AU749001B2 (en) * 1997-04-18 2002-06-13 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
AU5930898A (en) * 1998-01-28 1999-08-16 Procter & Gamble Company, The Antimicrobial hydrogel forming absorbent polymers
KR20010013712A (ko) * 1998-04-11 2001-02-26 엘레카빠 유로테라삐치 에스.피.에이. 수용성 케토프로펜 염을 함유하는 약학적 제제 및 그의 용도
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
CN1303305A (zh) * 1998-05-29 2001-07-11 金伯利-克拉克环球有限公司 用天然及合成聚合物加强异味吸收

Also Published As

Publication number Publication date
AU2002336472B2 (en) 2007-08-23
CA2461291A1 (en) 2003-04-17
JP2005523239A (ja) 2005-08-04
MXPA04002474A (es) 2004-05-31
EP1432459A1 (en) 2004-06-30
KR20040044950A (ko) 2004-05-31
KR100918887B1 (ko) 2009-09-23
AR037505A1 (es) 2004-11-17
WO2003030953A1 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
BR0109851A (pt) Composto, método para produzir o mesmo ou um sal deste, pró medicamento, composição farmacêutica, método para inibir a tirosina cinase, método para prevenir ou tratar câncer, e, uso de um composto ou de um sal ou pró medicamento deste
BR0010555A (pt) Inibidores de neuraminidases
PT1254144E (pt) Novos compostos de fosforo
BR0014075A (pt) Inibidores de quinase como agentes terapêuticos
BR0214096A (pt) Inibidores da pde9 para o tratamento de distúrbios cardiovasculares
BR0211750A (pt) Agente antiviral
BR9913654A (pt) Inibidores de p-38alfa quinase
ES2169871T3 (es) Empleo de poliacidos para el tratamiento de fertilizantes minerales que contienen un inhibidor de nitrificado.
BR0308495A (pt) Composto, formulação farmacêutica, métodos para ativar receptores de 5-ht1f, para inibir o extravasamento de proteìna neuronal, para tratar ou prevenir enxaqueca em um mamìfero e para preparar um composto, uso de um composto, e, processo para preparar um composto
BR9910122A (pt) Compostos amidina
BR9813468A (pt) Inibidores triazìnicos da angiogênese
NO324249B1 (no) Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater til fremstilling av derivatene
BR0113629A (pt) Inibidores da adesão celular mediada por alfa4
WO2008006718A3 (en) Synergistic anti-microbial mixtures of tropolone (derivatives) and selected compounds
ATE301460T1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
BR0210531A (pt) Derivados de ácido sulfÈnico
GB1392044A (en) Corrosion inhibiting composition
BRPI0510059A (pt) inibidores da transcriptase reversa não-nucleosìdica
BR0113389A (pt) Compostos que inibem a atividade do fator xa
WO2022006412A3 (en) Conjugates of ampk inhibitors and protac degraders and related uses
WO2005089256A3 (en) Antiangiogenic agents
BR0212679A (pt) Inibição de produção de exoproteìna usando composições aromáticas
BR0006299A (pt) Derivados da 4-oxo-2-ureìdo-1,4,5,6-tetra-hidro-pirimidina
BR0014615A (pt) Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b
EP0921122A4 (en) NEW EPOXYSUCCINAMIDE DERIVATIVES AND ASSOCIATED SALTS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.